Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Lowered to $168 at Morgan Stanley

May 8, 2026 6:18 AM
Morgan Stanley analyst Terence Flynn lowered the price target on Gilead Sciences (NASDAQ: GILD) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change